Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer

Neoadjuvant chemotherapy (NAC) is widely accepted as a primary treatment for inoperable or locally advanced breast cancer before definitive surgery. However, not all advanced breast cancers are sensitive to NAC. Contrast-enhanced ultrasonography (CEUS) has been considered to assess tumor response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiabao, Wang, Bao-Hua, He, Mengna, Fu, Peifen, Yao, Minya, Jiang, Tian’an
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753903/
https://www.ncbi.nlm.nih.gov/pubmed/36531048
http://dx.doi.org/10.3389/fonc.2022.1026647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753903/
https://www.ncbi.nlm.nih.gov/pubmed/36531048
http://dx.doi.org/10.3389/fonc.2022.1026647

Ejemplares similares